Sigrun Unger

Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

Diana Bonderman, Ingrid Pretsch, Regina Steringer‐Mascherbauer et al. · CHEST Journal · 2014 · 250 citations · Full text

Cinaciguat (BAY 58–2667) Improves Cardiopulmonary Hemodynamics in Patients With Acute Decompensated Heart Failure

Harald Lapp, Veselin Mitrović, Norbert Franz et al. · Circulation · 2009 · 147 citations · Full text

Single‐Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63‐2521: An Ascending‐Dose Study in Healthy Male Volunteers

Reiner Frey, Wolfgang Mück, Sigrun Unger et al. · The Journal of Clinical Pharmacology · 2008 · 111 citations

Hypertension, Healthy Subjects, Cardiovascular Pharmacology +18

First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa

Dirk Thomas, Friederike Kanefendt, Stephan Schwers et al. · Journal of Thrombosis and Haemostasis · 2021 · 79 citations · Full text

BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics

Dirk Thomas, Kirstin Thelen, Stefanie Kraff et al. · Research and Practice in Thrombosis and Haemostasis · 2019 · 76 citations · Full text